SB 64 prevents Nevada from recovering Medicaid benefits from ABLE accounts upon the death of the account holder. It prohibits the state from seeking repayment from leftover funds in an ABLE account or filing claims against the account, unless federal law requires it. This directly affects Nevada residents with disabilities who use the state’s ABLE Savings Program and receive Medicaid benefits. The bill also requires the state to stop any ongoing efforts to recover Medicaid funds from these accounts. The change aligns Nevada’s practice with federal protections for ABLE accounts, which shield these savings from affecting public benefit eligibility.
SB 231 establishes new rules for pharmacies and hospitals operating secure drug take-back bins to collect unused medications from homes. It requires clear signage about acceptable items, monitored access hours, regular inspections, and reporting theft/tampering to law enforcement within one business day. The bill prohibits collectors from charging customers for bin maintenance and shields compliant collectors from liability (except for gross negligence). Additionally, it allocates $500,000 from Nevada’s opioid settlement fund to help cover the cost of destroying collected medications.
SB 17 revises Nevada's preprosecution diversion program and substance use disorder treatment programs. It tightens eligibility for diversion by excluding defendants charged with specific misdemeanors (like domestic violence violations, DUI, or stalking) and those with prior convictions for certain offenses (including felonies or violent crimes). The bill also clarifies that all courts (district, justice, and municipal) can establish substance use treatment programs and allows provisional referrals to these programs pending clinical assessment. These changes directly affect defendants facing misdemeanor charges who might qualify for diversion or treatment programs. The bill passed unanimously and was signed into law on May 26, 2025.
AB 19 revises the composition and reporting requirements of Nevada's Statewide Substance Use Response Working Group. It adds new members including the Executive Director of the Department of Indigent Defense Services and representatives from specific county sizes (700,000+; 100,000-700,000; under 100,000), plus experts in substance use treatment, recovery advocates, and others. The bill also changes the annual report deadline from January 31 to August 1 and requires the Health Department's designee to come from its Division of Public and Behavioral Health. These changes directly affect the Working Group's membership structure and timing of its annual recommendations to state leadership.
SB 400-82 requires Medicaid managed care organizations to reinvest a portion of their annual profits into local programs addressing homelessness, including supportive housing, substance abuse treatment, and medication services in the communities they serve. It mandates cities with populations between 150,000 and 500,000 to contribute $1 million to $2 million annually to fund these initiatives through a newly established Fiscal Advisory Committee. The Department of Health and Human Services must allocate state appropriations to this committee to coordinate with health centers and manage homelessness programs aligned with federal Continuum of Care requirements. This bill directly affects Medicaid providers, participating cities, and state agencies responsible for homelessness services.
SB 150 requires Nevada's Department of Health and Human Services to request a federal increase in Medicaid reimbursement rates for opioid treatment programs by October 1, 2025. It specifically seeks to raise the rate to at least $15.34 per hour for medication-assisted treatment provided by opioid treatment program providers. This would directly affect opioid treatment providers who currently receive lower reimbursement rates under Nevada's Medicaid program. The request must follow federal guidelines for determining reimbursement rates and requires federal approval to take effect.
SB 216 provides $3 million annually from the State General Fund to United Citizens Foundation, Inc. for mental health, substance use disorder, and community resource services for K-12 students, families, and school staff. The bill requires the foundation to submit detailed spending reports to the Finance Committee by December 2026 and September 2027, and mandates that unspent funds revert to the state by specific deadlines (September 18, 2026, and September 17, 2027). It directly affects public school students, families, and personnel by funding support services within the education system. The bill becomes effective July 1, 2025, and currently has no further action taken.
SB 266 expands Nevada's Student Loan Repayment Program for healthcare providers in underserved communities by adding new professions to the eligible list. It specifically includes marriage and family therapists, clinical alcohol and drug counselors, and licensed/certified alcohol and drug counselors as "providers of health care" under the program. This change makes loan repayment benefits available to these mental health and substance abuse professionals who work in underserved areas. The bill amends NRS 226.454 to add these roles to the existing list of covered healthcare providers and takes effect July 1, 2025.
SB 377 requires Nevada health insurers to cover at least one non-opioid alternative for every medical purpose where opioids are commonly used and a non-opioid option exists. Insurers cannot impose stricter requirements (like prior authorization) on these alternatives than they do on opioids, and must exempt patients from extra medical management steps if a provider confirms the alternative is appropriate. The law applies to all health insurance policies sold in Nevada, including group and individual plans, with new policies required to comply starting January 1, 2026. It aims to expand access to safer pain management options while preventing insurers from creating barriers to non-opioid treatments.
SB 337 requires health care facilities, providers, and insurers to offer patients a "non-opioid directive" form (allowing patients to decline opioids) and provide non-opioid treatment alternatives under specific circumstances. Starting January 1, 2027, facilities and providers must offer non-opioid alternatives to patients who request them or have completed the directive, except in limited cases. The bill mandates insurers to provide the form to new enrollees and creates a state advisory board to monitor compliance and recommend policies on opioid alternatives. It applies to all licensed health facilities, providers prescribing opioids, and health insurers, with enforcement through regulatory reviews and potential payment reductions for violations.